Form 4 holding
Chief Medical Officer, Director
Evommune, Inc.
- Security class
- Common Stock
- Shares / value
- 270,818
- Estimated value
- $4,831,393
- Report date
- 09 Dec 2025
- Price
- $17.84
- Ownership
- Direct
Eugene Bauer
Insider Reports History
- Location
- New York, NY
- Signature
- /s/ Gregory S. Moss, Attorney-in-Fact
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Eugene Bauer:
Form 4 holding
Chief Medical Officer, Director
Evommune, Inc.
- Security class
- Employee Stock Option (Right to Buy)
- Shares / value
- 51,117
- Estimated value
- Report date
- 16 Apr 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Chief Medical Officer, Director
Evommune, Inc.
- Security class
- Series B Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 07 Nov 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Chief Medical Officer, Director
Evommune, Inc.
- Security class
- Series Seed Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 07 Nov 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director
Kadmon Holdings, Inc.
- Security class
- Common Stock
- Shares / value
- 0
- Estimated value
- Report date
- 09 Nov 2021
- Price
- $9.50
- Ownership
- Bauer Family 1995 Trust
Form 4 holding
Director
Kadmon Holdings, Inc.
- Security class
- Common Stock
- Shares / value
- 0
- Estimated value
- Report date
- 09 Nov 2021
- Price
- $9.50
- Ownership
- Direct
Form 4 holding
Director
Kadmon Holdings, Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 0
- Estimated value
- Report date
- 09 Nov 2021
- Price
- $5.54
- Ownership
- Direct
- Underlying class
- Common Stock, par value $0.001
- Underlying amount
Insider Reports Filed by Eugene Bauer
4
EVMN
Evommune, Inc.
- Report period
- 16 Apr 2026
- Transactions
- 1
- Transaction value
- $0
- Filing time
- 17 Apr 2026, 17:23
- Role
- Chief Medical Officer, Director
- Next action
- Open filing details
4
Evommune, Inc.
- Report period
- 09 Dec 2025
- Transactions
- 1
- Transaction value
- -$26,368
- Filing time
- 11 Dec 2025, 16:18
- Role
- Chief Medical Officer, Director
- Next action
- Open filing details
4
Evommune, Inc.
- Report period
- 08 Dec 2025
- Transactions
- 1
- Transaction value
- $0
- Filing time
- 19 Dec 2025, 16:06
- Role
- Chief Medical Officer, Director
- Next action
- Open filing details
4
Evommune, Inc.
- Report period
- 07 Nov 2025
- Transactions
- 3
- Transaction value
- $0
- Filing time
- 12 Nov 2025, 16:15
- Role
- Chief Medical Officer, Director
- Next action
- Open filing details
3
Evommune, Inc.
- Report period
- 05 Nov 2025
- Transactions
- 0
- Transaction value
- $0
- Filing time
- 05 Nov 2025, 19:59
- Role
- Chief Medical Officer, Director
- Next action
- Open filing details
4
Kadmon Holdings, Inc.
- Report period
- 09 Nov 2021
- Transactions
- 8
- Transaction value
- -$2,092,309
- Filing time
- 09 Nov 2021, 16:35
- Role
- Director
- Next action
- Open filing details
4
Kadmon Holdings, Inc.
- Report period
- 12 May 2021
- Transactions
- 1
- Transaction value
- $0
- Filing time
- 13 May 2021, 16:07
- Role
- Director
- Next action
- Open filing details